Results of a recent study have shown that simvastatin (Zocor) plus vitamin D is effective for the prevention of headache in adults with episodic migraine.
Despite improvements in radiographic diagnostic techniques, including magnetic resonance imaging (MRI), the misdiagnosis of multiple sclerosis (MS) is a common problem that can lead to treatment-related and psychosocial morbidity.
A recent study investigated the effects of alemtuzumab (Lemtrada) on disability measures in patients with Multiple Sclerosis (MS).
Nearly 3 times as many patients with newly diagnosed Parkinson’s disease had dependency in ≥1 activities of daily living (ADLs) compared with a healthy control group, a recent longitudinal, population-based study demonstrated.
Despite a dramatic increase in the use of thrombolytic therapy for acute ischemic stroke, 25% of eligible patients still do not receive this treatment, according to data from a national registry.
- Abuse-Deterrent Troxyca ER Approved for Chronic Pain
The past 2 decades have seen significant improvements in disease-modifying therapies (DMTs) for multiple sclerosis (MS), and with them a surge in prices in the cost of therapy with sales more than doubling just in the past few years. As a result, there has been a significant rise in the cost of care for patients with MS.
- Sleep Disturbances Lead to Cognitive Decline
- Alemtuzumab Demonstrates Superior Outcomes versus Interferon-ß-1a in Relapsing-Remitting Multiple Sclerosis
- Aprepitant Relieves Nausea Associated with Dihydroergotamine Use for Migraine
- Positive Effect of Hormone Therapy on Physical Function in Postmenopausal Women with Multiple Sclerosis
Findings from an ongoing, phase 3 clinical trial involving patients with relapsing-remitting multiple sclerosis (MS) reveal that hematopoietic stem-cell transplantation (HSCT) may be a feasible treatment option for reversing disability associated with MS.
Patients with early- versus late-onset epilepsy exhibited distinct differences in the origin of memory deficits, supporting the practice of subtyping patients by clinical characteristics to identify individualized predictors of cognitive dysfunction, according to the results of a new study.
- 1
- 2
Page 1 of 2
Results 1 - 10 of 18
Results 1 - 10 of 18
